The role of IL-27/Lag3 axis in regulating Foxp3+ regulatory T cell function
IL-27/Lag3轴在调节Foxp3调节性T细胞功能中的作用
基本信息
- 批准号:10264303
- 负责人:
- 金额:$ 39.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-15 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAnimal ModelAnimalsAntigen-Presenting CellsAntigensAttenuatedAutoantigensAutoimmune DiseasesCD4 Positive T LymphocytesCell physiologyCellsChronicClinicalDefectDevelopmentDiseaseDisease modelExperimental Autoimmune EncephalomyelitisFOXP3 geneFamilyGene ActivationGenerationsGoalsHistologicImmune responseImmunityIn VitroInflammationInflammatoryInflammatory ResponseInterleukin-10Interleukin-12IntestinesLymphocyte ActivationMediatingMicroarray AnalysisMultiple SclerosisMusMyelinNeuraxisPathogenesisPathway interactionsPlayRecoveryRegulationRegulatory T-LymphocyteReportingRoleSeveritiesSignal PathwaySignal TransductionT cell regulationT cell responseT-Cell ActivationTestingTissuesautoimmune inflammationcell typecytokinegenome-wideimmune activationimmunoregulationimprovedin vivomultiple sclerosis patientneuroinflammationnovelnovel strategiespreventresponsetargeted treatment
项目摘要
Abstract
Foxp3+ CD4 T cells (Tregs) play a key role in regulating immunity and tolerance. Defects in Treg
generation and/or functions are directly associated with uncontrolled immune activation leading to the
development of autoimmune diseases. Yet, the precise mechanisms by which Tregs express the
functions remain unclear. Multiple sclerosis (MS) is a myelin antigen specific autoimmune
inflammation of the central nervous system (CNS) mediated by myelin antigen specific Th17 type CD4
T cells. Experimental autoimmune encephalomyelitis (EAE) is an animal model that shares clinical
and histological features with MS, and is widely used to investigate the pathogenesis as well as to
develop an approach to treat the disease. Increasing evidence suggests that Treg function may be
dysregulated in MS patients or EAE bearing mice. Thus, identifying pathways that improve Treg
function is an issue of clinical importance to develop a potential therapy targeting Tregs. The major
goal of this application is to test the role of IL-27 in Treg function. We recently reported that IL-27
signaling in Tregs plays an essential role in suppressing Th17 type inflammation in the intestine. We
utilized a newly developed Treg-specific Il27ra-/- animal and found that Treg-specific IL-27R deficiency
results in a severe EAE. CNS infiltrating CD4 T cells producing proinflammatory cytokines were
uncontrolled in the presence of Il27ra-/- Tregs, while IL-10+ CD4 T cells implicated in regulation of
inflammatory responses remained unchanged. Genome wide microarray analysis revealed that IL-27
stimulation in Tregs induces Lag3, a CD4 like molecule implicated in negative regulation of T cell
activation. We then used a novel Treg-specific Lag3-/- animal and found that they also develop severe
EAE, suggesting that Treg expression of Lag3 may be critical to mediate IL-27-induced Treg function.
Finally, IL-27 prestimulation in Tregs significantly enhances suppressive function both in vitro and in
vivo. The overall hypothesis is that IL-27 controls Treg suppressive function during EAE and that Lag3
induced by IL-27 signaling plays a key role in mediating IL-27 effect on Tregs. We also propose that
the suppressive function of Tregs can be improved by IL-27 prestimulation, reversing ongoing
inflammation in the CNS. Three specific aims are proposed. Aim #1 will test the role of IL-27 signaling
on Treg function during EAE. Aim #2 will test To test the role of Lag3 during IL-27-mediated control of
Treg function. Aim #3 will test the mechanisms by which IL-27 prestimulated Tregs efficiently reverse
ongoing neuroinflammation. We anticipate that the results from this study will identify novel
mechanisms by which IL-27 modulates Treg function via Lag3 to downregulate inflammation in the
CNS. Completing the proposed studies will provide an important basis for the development of new
strategies targeting the IL-27/Lag3 axis in Tregs to treat MS, and chronic inflammation in other
tissues.
Abstract
Foxp3+ CD4 T cells (Tregs) play a key role in regulating immunity and tolerance. Defects in Treg
generation and/or functions are directly associated with uncontrolled immune activation leading to the
development of autoimmune diseases. Yet, the precise mechanisms by which Tregs express the
functions remain unclear. Multiple sclerosis (MS) is a myelin antigen specific autoimmune
inflammation of the central nervous system (CNS) mediated by myelin antigen specific Th17 type CD4
T cells. Experimental autoimmune encephalomyelitis (EAE) is an animal model that shares clinical
and histological features with MS, and is widely used to investigate the pathogenesis as well as to
develop an approach to treat the disease. Increasing evidence suggests that Treg function may be
dysregulated in MS patients or EAE bearing mice. Thus, identifying pathways that improve Treg
function is an issue of clinical importance to develop a potential therapy targeting Tregs. The major
goal of this application is to test the role of IL-27 in Treg function. We recently reported that IL-27
signaling in Tregs plays an essential role in suppressing Th17 type inflammation in the intestine. We
utilized a newly developed Treg-specific Il27ra-/- animal and found that Treg-specific IL-27R deficiency
results in a severe EAE. CNS infiltrating CD4 T cells producing proinflammatory cytokines were
uncontrolled in the presence of Il27ra-/- Tregs, while IL-10+ CD4 T cells implicated in regulation of
inflammatory responses remained unchanged. Genome wide microarray analysis revealed that IL-27
stimulation in Tregs induces Lag3, a CD4 like molecule implicated in negative regulation of T cell
activation. We then used a novel Treg-specific Lag3-/- animal and found that they also develop severe
EAE, suggesting that Treg expression of Lag3 may be critical to mediate IL-27-induced Treg function.
Finally, IL-27 prestimulation in Tregs significantly enhances suppressive function both in vitro and in
vivo. The overall hypothesis is that IL-27 controls Treg suppressive function during EAE and that Lag3
induced by IL-27 signaling plays a key role in mediating IL-27 effect on Tregs. We also propose that
the suppressive function of Tregs can be improved by IL-27 prestimulation, reversing ongoing
inflammation in the CNS. Three specific aims are proposed. Aim #1 will test the role of IL-27 signaling
on Treg function during EAE. Aim #2 will test To test the role of Lag3 during IL-27-mediated control of
Treg function. Aim #3 will test the mechanisms by which IL-27 prestimulated Tregs efficiently reverse
ongoing neuroinflammation. We anticipate that the results from this study will identify novel
mechanisms by which IL-27 modulates Treg function via Lag3 to downregulate inflammation in the
CNS. Completing the proposed studies will provide an important basis for the development of new
strategies targeting the IL-27/Lag3 axis in Tregs to treat MS, and chronic inflammation in other
tissues.
项目成果
期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Lymphocyte activation gene 3 (Lag3) supports Foxp3 + Treg cell function by restraining c-Myc-dependent aerobic glycolysis.
淋巴细胞激活基因 3 (Lag3) 通过抑制 c-Myc 依赖性有氧糖酵解来支持 Foxp3 Treg 细胞功能。
- DOI:10.1101/2023.02.13.528371
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Kim,Dongkyun;Kim,Giha;Yu,Rongzhen;Lee,Juyeun;Kim,Sohee;Qiu,Kevin;Montauti,Elena;Fang,Deyu;Chandel,NavdeepS;Choi,Jaehyuk;Min,Booki
- 通讯作者:Min,Booki
Single-Cell Analysis Uncovers Striking Cellular Heterogeneity of Lung-Infiltrating Regulatory T Cells during Eosinophilic versus Neutrophilic Allergic Airway Inflammation.
单细胞分析揭示了嗜酸性粒细胞与中性粒细胞过敏性气道炎症期间肺浸润调节性 T 细胞的惊人细胞异质性。
- DOI:10.4049/jimmunol.2300646
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Iamsawat,Supinya;Yu,Rongzhen;Kim,Sohee;Dvorina,Nina;Qiu,Kevin;Choi,Jaehyuk;Baldwin3rd,WilliamM;Min,Booki
- 通讯作者:Min,Booki
Cell type specific IL-27p28 (IL-30) deletion in mice uncovers an unexpected regulatory function of IL-30 in autoimmune inflammation.
- DOI:10.1038/s41598-023-27413-w
- 发表时间:2023-02-01
- 期刊:
- 影响因子:4.6
- 作者:
- 通讯作者:
Spontaneous T Cell Proliferation: A Physiologic Process to Create and Maintain Homeostatic Balance and Diversity of the Immune System.
- DOI:10.3389/fimmu.2018.00547
- 发表时间:2018
- 期刊:
- 影响因子:7.3
- 作者:Min B
- 通讯作者:Min B
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Booki Min其他文献
Booki Min的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Booki Min', 18)}}的其他基金
miR-342, a novel glucocorticoid-responsive miRNA necessary for Foxp3+ regulatory T cell function
miR-342,一种新的糖皮质激素反应性 miRNA,是 Foxp3 调节 T 细胞功能所必需的
- 批准号:
10671943 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids
Foxp3 调节性 T 细胞依赖性糖皮质激素治疗过敏性炎症
- 批准号:
10447598 - 财政年份:2020
- 资助金额:
$ 39.75万 - 项目类别:
Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids
Foxp3 调节性 T 细胞依赖性糖皮质激素治疗过敏性炎症
- 批准号:
10218031 - 财政年份:2020
- 资助金额:
$ 39.75万 - 项目类别:
Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids
Foxp3 调节性 T 细胞依赖性糖皮质激素治疗过敏性炎症
- 批准号:
9982786 - 财政年份:2019
- 资助金额:
$ 39.75万 - 项目类别:
Mechanism of basophil mediated immune modulation
嗜碱性粒细胞介导的免疫调节机制
- 批准号:
7897737 - 财政年份:2009
- 资助金额:
$ 39.75万 - 项目类别:
Mechanism of basophil mediated immune modulation
嗜碱性粒细胞介导的免疫调节机制
- 批准号:
7737907 - 财政年份:2009
- 资助金额:
$ 39.75万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists